Key | % Net Assets |
---|---|
![]() |
6.9% |
![]() |
5.5% |
![]() |
5.0% |
![]() |
5.0% |
![]() |
77.6% |
Name | % Net Assets |
---|---|
AstraZeneca | 6.9% |
Vodafone Group | 5.5% |
Resolution | 5.0% |
BP | 5.0% |
GlaxoSmithKline | 5.0% |
Rentokil Initial | 4.1% |
Morrison Supermarkets | 3.9% |
Lloyds Banking Group | 3.7% |
Royal Bank of Scotland Group | 3.5% |
Barclays | 3.4% |
Key | % Net Assets |
---|---|
![]() | 30.00% |
![]() | 18.00% |
![]() | 17.40% |
![]() | 10.10% |
![]() | 7.80% |
Date | 25-Apr-2025 |
---|---|
NAV | 13,750.00p |
Currency | GBP |
Change | 20.00p |
% | 0.15% |
YTD change | 440.00p |
YTD % | 3.31% |
Fund Inception | 31/05/1987 |
---|---|
Fund Manager | Kevin Murphy / Nick Kirrage |
TER | 1.66 (25-Feb-2012) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | n/a |
Savings | £50 |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.12 |
You are here: research